Nafamostat mesylate prevents metastasis and dissemination of neuroblastoma through vascular endothelial growth factor inhibitionMari Morimoto, Masahiro Hirayama|Molecular and Clinical Oncology|2022Cited by 3
Pharmacologic inhibition of BMI1 exerts antitumor effects against MYCN-amplified neuroblastoma, with activation of the p53 pathwayMasahiro Hirayama, Mineyoshi Aoyama|Scientific Reports|2025Cited by 0